Canada markets open in 4 hours 28 minutes

  • S&P/TSX
    18,457.78
    +76.82(+0.42%)

  • S&P 500
    3,821.35
    -20.59(-0.54%)

  • DOW
    31,802.44
    +306.14(+0.97%)

REGENXBIO Inc. (RGNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
39.28-0.65 (-1.63%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
35,233
154,567
35,233
218,505
10,393
Cost of Revenue
8,241
35,714
8,241
9,640
1,709
Gross Profit
26,992
118,853
26,992
208,865
8,684
Operating Expenses
Research Development
124,185
166,294
124,185
83,873
57,224
Selling General and Administrative
51,815
63,817
51,815
36,850
27,229
Total Operating Expenses
175,990
238,086
175,990
120,765
84,569
Operating Income or Loss
-148,998
-119,233
-148,998
88,100
-75,885
Interest Expense
771
771
-
-
-
Total Other Income/Expenses Net
48,559
9,723
48,559
7,070
2,716
Income Before Tax
-97,488
-106,010
-97,488
104,116
-73,169
Income Tax Expense
-2,755
5,240
-2,755
4,179
-
Income from Continuing Operations
-94,733
-111,250
-94,733
99,937
-73,169
Net Income
-94,733
-111,250
-94,733
99,937
-73,169
Net Income available to common shareholders
-94,733
-111,250
-94,733
99,937
-73,169
Basic EPS
-
-2.98
-2.58
2.99
-2.45
Diluted EPS
-
-2.98
-2.58
2.73
-2.45
Basic Average Shares
-
37,281
36,690
33,427
29,878
Diluted Average Shares
-
37,281
36,690
36,648
29,878
EBITDA
-
-96,832
-141,846
92,082
-73,199